Dendrimers in combination with natural products and analogues as anti-cancer agents. 2018

Serge Mignani, and João Rodrigues, and Helena Tomas, and Maria Zablocka, and Xiangyang Shi, and Anne-Marie Caminade, and Jean-Pierre Majoral
Université Paris Descartes, PRES Sorbonne Paris Cité, CNRS UMR 860, Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologique, 45, rue des Saints Peres, 75006, Paris, France.

For the first time, an overview of dendrimers in combination with natural products and analogues as anti-cancer agents is presented. This reflects the development of drug delivery systems, such as dendrimers, to tackle cancers. The most significant advantages of using dendrimers in nanomedicine are their high biocompatibility, good water solubility, and their entry - with or without encapsulated, complexed or conjugated drugs - through an endocytosis process. This strategy has accelerated over the years in order to develop nanosystems as nanocarriers, to decrease the intrinsic toxicity of anti-cancer agents, to decrease the drug side effects, to increase the efficacy of the treatment, and consequently to improve patient compliance.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000972 Antineoplastic Agents, Phytogenic Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. Antineoplastics, Botanical,Antineoplastics, Phytogenic,Agents, Phytogenic Antineoplastic,Botanical Antineoplastics,Phytogenic Antineoplastic Agents,Phytogenic Antineoplastics
D001688 Biological Products Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay. Biologic,Biologic Drug,Biologic Product,Biological,Biological Drug,Biological Medicine,Biological Product,Biologics,Biopharmaceutical,Natural Product,Natural Products,Biologic Drugs,Biologic Medicines,Biologic Pharmaceuticals,Biologic Products,Biological Drugs,Biological Medicines,Biologicals,Biopharmaceuticals,Products, Biological,Drug, Biologic,Drug, Biological,Drugs, Biologic,Drugs, Biological,Medicine, Biological,Medicines, Biologic,Medicines, Biological,Pharmaceuticals, Biologic,Product, Biologic,Product, Biological,Product, Natural
D016503 Drug Delivery Systems Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. Drug Targeting,Delivery System, Drug,Delivery Systems, Drug,Drug Delivery System,Drug Targetings,System, Drug Delivery,Systems, Drug Delivery,Targeting, Drug,Targetings, Drug
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D050091 Dendrimers Tree-like, highly branched, polymeric compounds. They grow three-dimensionally by the addition of shells of branched molecules to a central core. The overall globular shape and presence of cavities gives potential as drug carriers and CONTRAST AGENTS. Dendrimer,Dendritic Compounds,Dendritic Polymers,Dendrons,Compound, Dendritic,Dendritic Compound,Dendritic Polymer,Polymer, Dendritic,Polymers, Dendritic
D050997 Nanomedicine The branch of medicine concerned with the application of NANOTECHNOLOGY to the prevention and treatment of disease. It involves the monitoring, repair, construction, and control of human biological systems at the molecular level, using engineered nanodevices and NANOSTRUCTURES. (From Freitas Jr., Nanomedicine, vol 1, 1999).

Related Publications

Serge Mignani, and João Rodrigues, and Helena Tomas, and Maria Zablocka, and Xiangyang Shi, and Anne-Marie Caminade, and Jean-Pierre Majoral
January 2022, Combinatorial chemistry & high throughput screening,
Serge Mignani, and João Rodrigues, and Helena Tomas, and Maria Zablocka, and Xiangyang Shi, and Anne-Marie Caminade, and Jean-Pierre Majoral
January 2011, Current medicinal chemistry,
Serge Mignani, and João Rodrigues, and Helena Tomas, and Maria Zablocka, and Xiangyang Shi, and Anne-Marie Caminade, and Jean-Pierre Majoral
January 2020, Current medicinal chemistry,
Serge Mignani, and João Rodrigues, and Helena Tomas, and Maria Zablocka, and Xiangyang Shi, and Anne-Marie Caminade, and Jean-Pierre Majoral
February 2003, European journal of medicinal chemistry,
Serge Mignani, and João Rodrigues, and Helena Tomas, and Maria Zablocka, and Xiangyang Shi, and Anne-Marie Caminade, and Jean-Pierre Majoral
December 2015, Natural product communications,
Serge Mignani, and João Rodrigues, and Helena Tomas, and Maria Zablocka, and Xiangyang Shi, and Anne-Marie Caminade, and Jean-Pierre Majoral
March 2019, European journal of medicinal chemistry,
Serge Mignani, and João Rodrigues, and Helena Tomas, and Maria Zablocka, and Xiangyang Shi, and Anne-Marie Caminade, and Jean-Pierre Majoral
January 2014, Current clinical pharmacology,
Serge Mignani, and João Rodrigues, and Helena Tomas, and Maria Zablocka, and Xiangyang Shi, and Anne-Marie Caminade, and Jean-Pierre Majoral
August 2003, Mini reviews in medicinal chemistry,
Serge Mignani, and João Rodrigues, and Helena Tomas, and Maria Zablocka, and Xiangyang Shi, and Anne-Marie Caminade, and Jean-Pierre Majoral
January 2019, Chinese medicine,
Serge Mignani, and João Rodrigues, and Helena Tomas, and Maria Zablocka, and Xiangyang Shi, and Anne-Marie Caminade, and Jean-Pierre Majoral
July 2012, Current drug targets,
Copied contents to your clipboard!